Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


Articles published in Epidemiol Infect

Retrieve available abstracts of 252 articles:
HTML format



Single Articles


    November 2021
  1. TATSI EB, Filippatos F, Michos A
    SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence.
    Epidemiol Infect. 2021;149:e237.
    PubMed     Abstract available


  2. BAYS D, Bennett E, Finnie T
    What effect might border screening have on preventing the importation of COVID-19 compared with other infections? A modelling study.
    Epidemiol Infect. 2021;149:e238.
    PubMed     Abstract available


    October 2021
  3. NICHOLS M, Gollarza L, Palacios A, Stapleton GS, et al
    Salmonella illness outbreaks linked to backyard poultry purchasing during the COVID-19 pandemic: United States, 2020.
    Epidemiol Infect. 2021;149:e234.
    PubMed     Abstract available


  4. JUUTINEN A, Sarvikivi E, Laukkanen-Nevala P, Helve O, et al
    Closing lower secondary schools had no impact on COVID-19 incidence in 13-15-year-olds in Finland.
    Epidemiol Infect. 2021;149:e233.
    PubMed     Abstract available


  5. MANCILLA-GALINDO J, Kammar-Garcia A, Martinez-Esteban A, Meza-Comparan HD, et al
    COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptoms.
    Epidemiol Infect. 2021;149:e230.
    PubMed     Abstract available


  6. AEMRO A, Amare NS, Shetie B, Chekol B, et al
    Determinants of COVID-19 vaccine hesitancy among health care workers in Amhara region referral hospitals, Northwest Ethiopia: a cross-sectional study.
    Epidemiol Infect. 2021;149:e225.
    PubMed     Abstract available


  7. SINGH C, Naik BN, Pandey S, Biswas B, et al
    Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.
    Epidemiol Infect. 2021;149:e224.
    PubMed     Abstract available


    September 2021
  8. KEITA MB, Pierre F, Ndjomou J, Traore B, et al
    The first epidemiological and virological influenza surveillance in the Republic of Guinea revealed the predominance of influenza A/H3N2 and B Victoria viruses.
    Epidemiol Infect. 2021 Sep 28:1-20. doi: 10.1017/S0950268821001965.
    PubMed    


  9. SCHOEPS A, Hoffmann D, Tamm C, Vollmer B, et al
    Surveillance of SARS-CoV-2 transmission in educational institutions, August to December 2020, Germany.
    Epidemiol Infect. 2021;149:e213.
    PubMed     Abstract available


  10. AKTAS YILDIRIM S, Sarikaya ZT, Ulugol H, Ozata S, et al
    Are surgical and non-operating room intervention safe in the COVID-19 pandemic? A retrospective study.
    Epidemiol Infect. 2021;149:e210.
    PubMed     Abstract available


  11. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e203.
    PubMed    


  12. SPINICCI M, Pengue L, Bartolozzi D, Quercioli M, et al
    Soccer in the time of COVID-19: 1 year report from an Italian top league club, March 2020-February 2021.
    Epidemiol Infect. 2021;149:e207.
    PubMed     Abstract available


    August 2021
  13. ABU JABAL K, Ben-Amram H, Beiruti K, Brimat I, et al
    SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
    Epidemiol Infect. 2021;149:e239.
    PubMed     Abstract available


  14. ALPCAN A, Tursun S, Kandur Y
    Vitamin D levels in children with COVID-19: a report from Turkey.
    Epidemiol Infect. 2021;149:e180.
    PubMed     Abstract available


  15. NAESENS R, Mertes H, Clukers J, Herzog S, et al
    SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital.
    Epidemiol Infect. 2021;149:e172.
    PubMed     Abstract available


  16. BAUMEISTER A, Corrin T, Abid H, Young KM, et al
    The quality of systematic reviews and other synthesis in the time of COVID-19.
    Epidemiol Infect. 2021;149:e182.
    PubMed     Abstract available


  17. CHENG CH, Chow CL, Chow WK
    A discussion on the minimum required number of tests in two common pooling test methods for SARS-CoV-2.
    Epidemiol Infect. 2021;149:e179.
    PubMed     Abstract available


  18. MELOTTI R, Scaggiante F, Falciani M, Weichenberger CX, et al
    Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley.
    Epidemiol Infect. 2021;149:e194.
    PubMed     Abstract available


  19. KELLY G, Petti S, Noah N
    Covid-19, non-Covid-19 and excess mortality rates not comparable across countries.
    Epidemiol Infect. 2021;149:e176.
    PubMed     Abstract available


  20. ALVES JD, Abade AS, Peres WP, Borges JE, et al
    Impact of COVID-19 on the indigenous population of Brazil: a geo-epidemiological study.
    Epidemiol Infect. 2021;149:e185.
    PubMed     Abstract available


    July 2021
  21. OTTAVIANO E, Parodi C, Borghi E, Massa V, et al
    Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience, Milan, Italy, March 2021.
    Epidemiol Infect. 2021;149:e171.
    PubMed     Abstract available


  22. YI B, Poetsch AR, Stadtmuller M, Rost F, et al
    Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave.
    Epidemiol Infect. 2021;149:e177.
    PubMed     Abstract available


  23. CARLTON LH, Chen T, Whitcombe AL, McGregor R, et al
    Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.
    Epidemiol Infect. 2021;149:e173.
    PubMed     Abstract available


  24. YAKOB L
    Isolation thresholds for curbing SARS-CoV-2 resurgence.
    Epidemiol Infect. 2021;149:e168.
    PubMed     Abstract available


  25. THOMAS BS, Marks NA
    Estimating the case fatality ratio for COVID-19 using a time-shifted distribution analysis.
    Epidemiol Infect. 2021;149:e197.
    PubMed     Abstract available


  26. BOENDER TS, Bender JK, Kruger A, Michaelis K, et al
    Factors preventing SARS-CoV-2 transmission during unintentional exposure in a GP practice: a cohort study of patient contacts; Germany, 2020.
    Epidemiol Infect. 2021;149:e161.
    PubMed     Abstract available


  27. AKHMETZHANOV AR
    Estimation of delay-adjusted all-cause excess mortality in the USA: March-December 2020.
    Epidemiol Infect. 2021;149:e156.
    PubMed     Abstract available


  28. DITE GS, Murphy NM, Allman R
    Development and validation of a clinical and genetic model for predicting risk of severe COVID-19.
    Epidemiol Infect. 2021;149:e162.
    PubMed     Abstract available


  29. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e193.
    PubMed     Abstract available


    June 2021
  30. CARDENAS VM
    RE: George et al. 'High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?'
    Epidemiol Infect. 2021;149:e151.
    PubMed    


  31. GEORGE CE, Inbaraj LR
    Re: George et al. High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e152.
    PubMed    


  32. GOZLAN Y, Reingold S, Koren R, Halpern O, et al
    SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses.
    Epidemiol Infect. 2021;149:e153.
    PubMed     Abstract available


  33. WOUDENBERG T, Eberle U, Marosevic D, Liebl B, et al
    Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e150.
    PubMed     Abstract available


  34. ZHANG R, Gao Y, Xie D, Lian R, et al
    Characteristics of systematic reviews evaluating treatments for COVID-19 registered in PROSPERO.
    Epidemiol Infect. 2021;149:e146.
    PubMed     Abstract available


  35. MALDONADO MD, Romero-Aibar J, Perez-San-Gregorio MA
    COVID-19 pandemic as a risk factor for the reactivation of herpes viruses.
    Epidemiol Infect. 2021;149:e145.
    PubMed     Abstract available


  36. DE MARCO VERISSIMO C, O'Brien C, Lopez Corrales J, Dorey A, et al
    Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    Epidemiol Infect. 2021;149:e140.
    PubMed     Abstract available


  37. GUVEN BB, Erturk T, Kompe O, Ersoy A, et al
    Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
    Epidemiol Infect. 2021;149:e137.
    PubMed     Abstract available


    May 2021
  38. JAIN J, Saurabh S, Kumar P, Verma MK, et al
    COVID-19 vaccine hesitancy among medical students in India.
    Epidemiol Infect. 2021;149:e132.
    PubMed     Abstract available


  39. MCDONALD SA, van den Wijngaard CC, Wielders CCH, Friesema IHM, et al
    Risk factors associated with the incidence of self-reported COVID-19-like illness: data from a web-based syndromic surveillance system in the Netherlands.
    Epidemiol Infect. 2021;149:e129.
    PubMed     Abstract available


  40. DE SOUZA ARAUJO AA, Quintans-Junior LJ, Heimfarth L, Schimieguel DM, et al
    Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
    Epidemiol Infect. 2021;149:e130.
    PubMed     Abstract available


  41. HAMMER CC, Cristea V, Dub T, Sivela J, et al
    High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.
    Epidemiol Infect. 2021;149:e123.
    PubMed     Abstract available


    April 2021
  42. MAJUMDAR P, Niyogi S
    SARS-CoV-2 mutations: the biological trackway towards viral fitness.
    Epidemiol Infect. 2021;149:e110.
    PubMed     Abstract available


  43. CRUZ EHM, Maciel JM, Clozato CL, Serpa MS, et al
    Simulation-based evaluation of school reopening strategies during COVID-19: A case study of Sao Paulo, Brazil.
    Epidemiol Infect. 2021;149:e118.
    PubMed     Abstract available


  44. ZHAO S, Yang Z, Musa SS, Ran J, et al
    Attach importance of the bootstrap t test against Student's t test in clinical epidemiology: a demonstrative comparison using COVID-19 as an example.
    Epidemiol Infect. 2021;149:e107.
    PubMed     Abstract available


  45. VERA-ZERTUCHE JM, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, et al
    Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
    Epidemiol Infect. 2021;149:e109.
    PubMed     Abstract available


  46. MOUSSA R, Majdalani S
    Use of the Hayami diffusive wave equation to model the relationship infected-recoveries-deaths of Covid-19 pandemic.
    Epidemiol Infect. 2021;149:e138.
    PubMed     Abstract available


  47. SHARIF N, Ahmed SN, Opu RR, Daullah MU, et al
    Impact of meteorological parameters and population density on variants of SARS-CoV-2 and outcome of COVID-19 pandemic in Japan.
    Epidemiol Infect. 2021;149:e103.
    PubMed     Abstract available


  48. KIM SH, Kim YJ, Jeong YJ, Park JH, et al
    Construction of a non-contact community treatment centre for asymptomatic and mildly symptomatic COVID-19 patients during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e111.
    PubMed     Abstract available


  49. LOPEZ-CHEDA A, Jacome MA, Cao R, De Salazar PM, et al
    Estimating lengths-of-stay of hospitalised COVID-19 patients using a non-parametric model: a case study in Galicia (Spain).
    Epidemiol Infect. 2021;149:e102.
    PubMed     Abstract available


  50. KSHATRI JS, Bhattacharya D, Praharaj I, Mansingh A, et al
    Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys.
    Epidemiol Infect. 2021;149:e139.
    PubMed     Abstract available


  51. ALLEN N, Riain UN, Conlon N, Ferenczi A, et al
    Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Epidemiol Infect. 2021;149:e157.
    PubMed     Abstract available


  52. DRESSLER A, Finci I, Wagner-Wiening C, Eichner M, et al
    Epidemiological analysis of 3,219 COVID-19 outbreaks in the state of Baden-Wuerttemberg, Germany.
    Epidemiol Infect. 2021;149:e101.
    PubMed     Abstract available


  53. BAGGIO JAO, Machado MF, Carmo RFD, Armstrong ADC, et al
    COVID-19 in Brazil: spatial risk, social vulnerability, human development, clinical manifestations and predictors of mortality - a retrospective study with data from 59 695 individuals.
    Epidemiol Infect. 2021;149:e100.
    PubMed     Abstract available


  54. LUO S, Xin M, Wang S, Zhao J, et al
    Behavioural intention of receiving COVID-19 vaccination, social media exposures and peer discussions in China.
    Epidemiol Infect. 2021;149:e158.
    PubMed     Abstract available


  55. ZARE F, Teimouri M, Khosravi A, Rohani-Rasaf M, et al
    COVID-19 re-infection in Shahroud, Iran: a follow-up study.
    Epidemiol Infect. 2021;149:e159.
    PubMed     Abstract available


  56. MARCO A, Gallego C, Perez-Caceres V, Guerrero RA, et al
    Public health response to an outbreak of SARS-CoV2 infection in a Barcelona prison.
    Epidemiol Infect. 2021;149:e91.
    PubMed     Abstract available


  57. KARIMZADEH S, Bhopal R, Nguyen Tien H
    Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.
    Epidemiol Infect. 2021;149:e96.
    PubMed     Abstract available


  58. HU HY, Yan F, Zhu JM, Karuno AP, et al
    Intercontinental transmission and local demographic expansion of SARS-CoV-2.
    Epidemiol Infect. 2021;149:e94.
    PubMed     Abstract available


  59. SEMENZA JC, Adlhoch C, Baka A, Broberg E, et al
    COVID-19 research priorities for non-pharmaceutical public health and social measures.
    Epidemiol Infect. 2021;149:e87.
    PubMed     Abstract available


  60. MASSAD E, Amaku M, Tadeu Covas D, Fernandes Lopez L, et al
    Estimating the effects of reopening of schools on the course of the epidemic of COVID-19.
    Epidemiol Infect. 2021;149:e86.
    PubMed     Abstract available


  61. MAO Y, Tan YR, Thein TL, Chai YAL, et al
    Identifying COVID-19 cases in outpatient settings.
    Epidemiol Infect. 2021;149:e92.
    PubMed     Abstract available


    March 2021
  62. WANG K, Wang X, Du J, Liu C, et al
    Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe vs. common disease.
    Epidemiol Infect. 2021;149:e81.
    PubMed     Abstract available


  63. MUKHERJEE A, Anand T, Agarwal A, Singh H, et al
    SARS-CoV-2 re-infection: development of an epidemiological definition from India.
    Epidemiol Infect. 2021;149:e82.
    PubMed     Abstract available


  64. BLANCO N, Stafford KA, Lavoie MC, Brandenburg A, et al
    A simple model for the total number of SARS-CoV-2 infections on a national level.
    Epidemiol Infect. 2021;149:e80.
    PubMed     Abstract available


  65. GALLO O, Peris A, Trotta M, Orlando P, et al
    Epidemiological analysis of a COVID-19 outbreak associated with an infected surgeon.
    Epidemiol Infect. 2021;149:e77.
    PubMed     Abstract available


  66. OGIMI C, Qu P, Boeckh M, Bender Ignacio RA, et al
    Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.
    Epidemiol Infect. 2021;149:e75.
    PubMed     Abstract available


  67. KUCHENHOFF H, Gunther F, Hohle M, Bender A, et al
    Analysis of the early COVID-19 epidemic curve in Germany by regression models with change points.
    Epidemiol Infect. 2021;149:e68.
    PubMed     Abstract available


  68. KOZER E, Rinott E, Kozer G, Bar-Haim A, et al
    Presence of SARS-CoV-2 RNA on playground surfaces and water fountains.
    Epidemiol Infect. 2021;149:e67.
    PubMed     Abstract available


  69. ELSON R, Davies TM, Lake IR, Vivancos R, et al
    The spatio-temporal distribution of COVID-19 infection in England between January and June 2020.
    Epidemiol Infect. 2021;149:e73.
    PubMed     Abstract available


  70. TAKEFUJI Y
    Fourier analysis using the number of COVID-19 daily deaths in the US.
    Epidemiol Infect. 2021;149:e64.
    PubMed     Abstract available


  71. BOHM S, Woudenberg T, Chen D, Marosevic DV, et al
    Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e65.
    PubMed     Abstract available


    February 2021
  72. CASTRO RR, Santos RSC, Sousa GJB, Pinheiro YT, et al
    Spatial dynamics of the COVID-19 pandemic in Brazil.
    Epidemiol Infect. 2021;149:e60.
    PubMed     Abstract available


  73. MICHOS A, Savvidou P, Syridou G, Eleftheriou E, et al
    SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study.
    Epidemiol Infect. 2021;149:e70.
    PubMed     Abstract available


  74. CHENG A, Chen Y, Gao Y, Sun P, et al
    Mobile isolation wards in a fever clinic: a novel operation model during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e61.
    PubMed     Abstract available


  75. HONG K, Yum SJ, Kim JH, Chun BC, et al
    Re-estimation of basic reproduction number of COVID-19 based on the epidemic curve by symptom onset date.
    Epidemiol Infect. 2021;149:e53.
    PubMed     Abstract available


  76. DUQUE MP, Lucaccioni H, Costa C, Marques R, et al
    COVID-19 symptoms: a case-control study, Portugal, March-April 2020.
    Epidemiol Infect. 2021;149:e54.
    PubMed     Abstract available


  77. LEHMANN J, Giesinger JM, Rumpold G, Borena W, et al
    Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria.
    Epidemiol Infect. 2021;149:e52.
    PubMed     Abstract available


  78. ZHAO K, Ai L, Zhao Y, Wang T, et al
    Diagnostic value of using a combination of nucleic acid and specific antibody tests for SARS-CoV-2 in coronavirus disease 2019.
    Epidemiol Infect. 2021;149:e62.
    PubMed     Abstract available


  79. LELIS DA SILVA F, Dias Pita J, Gomes MDA, Lelis da Silva AP, et al
    Intraregional propagation of Covid-19 cases in Para, Brazil: assessment of isolation regime to lockdown.
    Epidemiol Infect. 2021;149:e72.
    PubMed     Abstract available


  80. GAO Y, Chen Y, Liu M, Niu M, et al
    Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
    Epidemiol Infect. 2021;149:e66.
    PubMed     Abstract available


  81. MIYAMA T, Iritani N, Nishio T, Ukai T, et al
    Seasonal shift in epidemics of respiratory syncytial virus infection in Japan.
    Epidemiol Infect. 2021;149:e55.
    PubMed     Abstract available


  82. AI J, Shi N, Shi Y, Xu K, et al
    Epidemiologic characteristics and influencing factors of cluster infection of COVID-19 in Jiangsu Province.
    Epidemiol Infect. 2021;149:e48.
    PubMed     Abstract available


  83. SHANG C, Yang Y, Chen GY, Shang XD, et al
    A simple transmission dynamics model for predicting the evolution of COVID-19 under control measures in China.
    Epidemiol Infect. 2021;149:e43.
    PubMed     Abstract available


  84. BAILIE CR, Franklin L, Nicholson S, Mordant F, et al
    Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort.
    Epidemiol Infect. 2021;149:e44.
    PubMed     Abstract available


  85. WEIBELZAHL S, Reiter J, Duden G
    Depression and anxiety in healthcare professionals during the COVID-19 pandemic.
    Epidemiol Infect. 2021;149:e46.
    PubMed     Abstract available


  86. GEORGE CE, Inbaraj LR, Chandrasingh S, de Witte LP, et al
    High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?
    Epidemiol Infect. 2021;149:e39.
    PubMed     Abstract available


  87. KAMAR A, Maalouf N, Hitti E, El Eid G, et al
    Challenge of forecasting demand of medical resources and supplies during a pandemic: A comparative evaluation of three surge calculators for COVID-19.
    Epidemiol Infect. 2021;149:e51.
    PubMed     Abstract available


  88. SINGH RKS, Malik MZ, Singh RKB
    Diversity of SARS-CoV-2 isolates driven by pressure and health index.
    Epidemiol Infect. 2021;149:e38.
    PubMed     Abstract available


    January 2021
  89. PETT J, McAleavey P, McGurnaghan P, Spiers R, et al
    Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020.
    Epidemiol Infect. 2021;149:e36.
    PubMed     Abstract available


  90. PRANATA R, Lim MA, Yonas E, Huang I, et al
    Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis.
    Epidemiol Infect. 2021;149:e40.
    PubMed     Abstract available


  91. ZAVASCKI AP
    Urgent need for evaluation of point-of-care tests as an RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
    Epidemiol Infect. 2021;149:e35.
    PubMed    


  92. CHOW WK, Chow CL
    Response to Letter to Editor by Zavascki A.P.: Urgent need for evaluating point-of-care tests as a RT-PCR-sparing strategy for the diagnosis of Covid-19 in symptomatic patients.
    Epidemiol Infect. 2021;149:e33.
    PubMed    


  93. WANG Y, Luo H, Liu S, Hao T, et al
    Respiratory failure among patients with COVID-19 in Jiangsu province, China: a multicentre retrospective cohort study.
    Epidemiol Infect. 2021;149:e31.
    PubMed     Abstract available


  94. SETHI SM, Ahmed AS, Hanif S, Aqeel M, et al
    Subcutaneous emphysema and pneumomediastinum in patients with COVID-19 disease; case series from a tertiary care hospital in Pakistan.
    Epidemiol Infect. 2021;149:e37.
    PubMed     Abstract available


  95. VENTURELLI S, Benatti SV, Casati M, Binda F, et al
    Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation.
    Epidemiol Infect. 2021;149:e32.
    PubMed     Abstract available


  96. WENG CH, Saal A, McGuire DC, Chan PA, et al
    Persistently high SARS-CoV-2 positivity rate and incidence for Hispanic/Latinos during state reopening in an urban setting: a retrospective cohort study.
    Epidemiol Infect. 2021;149:e25.
    PubMed     Abstract available


  97. LE TD, Bosworth M, Ledlow G, Le TT, et al
    Influences of reopening businesses and social venues: COVID-19 incidence rate in East Texas county.
    Epidemiol Infect. 2021;149:e28.
    PubMed     Abstract available


  98. WEI J, Guo S, Long E, Zhang L, et al
    Why does the spread of COVID-19 vary greatly in different countries? Revealing the efficacy of face masks in epidemic prevention.
    Epidemiol Infect. 2021;149:e24.
    PubMed     Abstract available


  99. ISHIKAWA G, Argenti G, Fadel CB
    Non-specific blood tests as proxies for COVID-19 hospitalisation: are there plausible associations after excluding noisy predictors?
    Epidemiol Infect. 2021;149:e23.
    PubMed     Abstract available


  100. LI W, Gong J, Zhou J, Zhang L, et al
    An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Epidemiol Infect. 2021;149:e2.
    PubMed     Abstract available


  101. GE Y, Sun S, Shen Y
    Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York state: a preliminary report.
    Epidemiol Infect. 2021;149:e14.
    PubMed     Abstract available


  102. SALMON RL, Monaghan SP
    Who is dying from COVID-19 in the United Kingdom? A review of cremation authorisations from a single South Wales' crematorium.
    Epidemiol Infect. 2021;149:e13.
    PubMed     Abstract available


  103. SHARIF N, Dey SK
    Impact of population density and weather on COVID-19 pandemic and SARS-CoV-2 mutation frequency in Bangladesh.
    Epidemiol Infect. 2021;149:e16.
    PubMed     Abstract available


  104. LIU Y, Haussinger L, Steinacker JM, Dinse-Lambracht A, et al
    Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution.
    Epidemiol Infect. 2021;149:e19.
    PubMed     Abstract available


  105. ILESANMI OS, Afolabi AA, Akande A, Raji T, et al
    Infection prevention and control during COVID-19 pandemic: realities from health care workers in a north central state in Nigeria.
    Epidemiol Infect. 2021;149:e15.
    PubMed     Abstract available


  106. WEI ZY, Qiao R, Chen J, Huang J, et al
    The influence of pre-existing hypertension on coronavirus disease 2019 patients.
    Epidemiol Infect. 2021;149:e4.
    PubMed     Abstract available


  107. LIANG C, Shen L
    An analysis of coronavirus disease 2019 with spline regression at province level during first-level response to major public health emergency out of Hubei, China.
    Epidemiol Infect. 2021;149:e10.
    PubMed     Abstract available


  108. CHOW WK, Chow CL
    A discussion on implementing pooling detection tests of novel coronavirus (SARS-CoV-2) for a large population.
    Epidemiol Infect. 2021;149:e17.
    PubMed     Abstract available


  109. DENG L, Zhang J, Wang M, Chen L, et al
    Obesity is associated with severe COVID-19 but not death: a dose-response meta-analysis.
    Epidemiol Infect. 2021;149:e144.
    PubMed     Abstract available


    December 2020
  110. WEI C, Lee CC, Hsu TC, Hsu WT, et al
    Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries.
    Epidemiol Infect. 2020;149:e1.
    PubMed     Abstract available


  111. FERNANDEZ-SALINAS J, Aragon-Caqueo D, Valdes G, Laroze D, et al
    Modelling pool testing for SARS-CoV-2: addressing heterogeneity in populations.
    Epidemiol Infect. 2020;149:e9.
    PubMed     Abstract available


  112. YANG J, Ma Z, Lei Y
    A meta-analysis of the association between obesity and COVID-19.
    Epidemiol Infect. 2020;149:e11.
    PubMed     Abstract available


  113. ARINO J, Bajeux N, Portet S, Watmough J, et al
    Quarantine and the risk of COVID-19 importation.
    Epidemiol Infect. 2020;148:e298.
    PubMed     Abstract available


  114. YUNG CF, Saffari E, Liew C
    Time to Rt < 1 for COVID-19 public health lockdown measures.
    Epidemiol Infect. 2020;148:e301.
    PubMed     Abstract available


  115. YOUNG BE, Mak TM, Ang LW, Sadarangani S, et al
    Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness.
    Epidemiol Infect. 2020 Dec 2:1-29. doi: 10.1017/S0950268820002952.
    PubMed    


  116. DE ALMEIDA GB, Pronunciate M, Grotto RMT, Azevedo Pugliesi E, et al
    Two hundred days of COVID-19 in Sao Paulo State, Brazil.
    Epidemiol Infect. 2020;148:e295.
    PubMed     Abstract available


  117. ANDRADE LA, Gomes DS, Lima SVMA, Duque AM, et al
    COVID-19 mortality in an area of northeast Brazil: epidemiological characteristics and prospective spatiotemporal modelling.
    Epidemiol Infect. 2020;148:e288.
    PubMed     Abstract available


  118. MO P, Deng L, Liu X, Gao S, et al
    Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e293.
    PubMed     Abstract available


    November 2020
  119. MANCILLA-GALINDO J, Vera-Zertuche JM, Navarro-Cruz AR, Segura-Badilla O, et al
    Development and validation of the patient history COVID-19 (PH-Covid19) scoring system: a multivariable prediction model of death in Mexican patients with COVID-19.
    Epidemiol Infect. 2020;148:e286.
    PubMed     Abstract available


  120. THOMPSON JV, Meghani NJ, Powell BM, Newell I, et al
    Patient characteristics and predictors of mortality in 470 adults admitted to a district general hospital in England with Covid-19.
    Epidemiol Infect. 2020;148:e285.
    PubMed     Abstract available


  121. CAO Y, Wang Y, Das A, Pan CQ, et al
    Transmission dynamics of COVID-19 among index case family clusters in Beijing, China.
    Epidemiol Infect. 2020;149:e74.
    PubMed     Abstract available


  122. HABONIMANA D, Ouedraogo L, Ndirahisha E, Misago N, et al
    Understanding the influence of the COVID-19 pandemic on hospital-based mortality in Burundi: a cross-sectional study comparing two time periods.
    Epidemiol Infect. 2020;148:e280.
    PubMed     Abstract available


  123. SANTAMARIA L, Hortal J
    Chasing the ghost of infection past: identifying thresholds of change during the COVID-19 infection in Spain.
    Epidemiol Infect. 2020;148:e282.
    PubMed     Abstract available


  124. SUNG J, Choudry N, Bachour R
    Development and validation of a simple risk score for diagnosing COVID-19 in the emergency room.
    Epidemiol Infect. 2020;148:e273.
    PubMed     Abstract available


  125. SULYOK M, Walker M
    Community movement and COVID-19: a global study using Google's Community Mobility Reports.
    Epidemiol Infect. 2020;148:e284.
    PubMed     Abstract available


  126. SHAKIBA M, Nazemipour M, Heidarzadeh A, Mansournia MA, et al
    Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey.
    Epidemiol Infect. 2020;148:e300.
    PubMed     Abstract available


  127. KAZANCIOGLU S, Bastug A, Ozbay BO, Kemirtlek N, et al
    The Role of Hematological Parameters in Patients with Coronavirus Disease 2019 and Influenza Virus Infection.
    Epidemiol Infect. 2020 Nov 5:1-16. doi: 10.1017/S095026882000271.
    PubMed    


  128. GREBE G, Velez JA, Tiutiunnyk A, Aragon-Caqueo D, et al
    Dynamic quarantine: a comparative analysis of the Chilean public health response to COVID-19.
    Epidemiol Infect. 2020;148:e270.
    PubMed     Abstract available


  129. GURSAKAL N, Batmaz B, Aktuna G
    Drawing transmission graphs for COVID-19 in the perspective of network science.
    Epidemiol Infect. 2020;148:e269.
    PubMed     Abstract available


    October 2020
  130. ISLAM MZ, Riaz BK, Islam ANMS, Khanam F, et al
    Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 28th day of the disease course: a retrospective cohort study in Bangladesh.
    Epidemiol Infect. 2020;148:e263.
    PubMed     Abstract available


  131. RIVERA R, Rosenbaum JE, Quispe W
    Excess mortality in the United States during the first three months of the COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e264.
    PubMed     Abstract available


  132. MAJUMDAR P, Niyogi S
    ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
    Epidemiol Infect. 2020;148:e262.
    PubMed     Abstract available


  133. MEIKSIN A
    Dynamics of COVID-19 transmission including indirect transmission mechanisms: a mathematical analysis.
    Epidemiol Infect. 2020;148:e257.
    PubMed     Abstract available


  134. ZHANG SX, Graf-Vlachy L, Looi KH, Su R, et al
    Social media use as a predictor of handwashing during a pandemic: evidence from COVID-19 in Malaysia.
    Epidemiol Infect. 2020;148:e261.
    PubMed     Abstract available


  135. ZENG L, Wang S, Cai J, Sun S, et al
    Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis.
    Epidemiol Infect. 2020;148:e266.
    PubMed     Abstract available


  136. DE SALAZAR PM, Gomez-Barroso D, Pampaka D, Gil JM, et al
    Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain.
    Epidemiol Infect. 2020;148:e268.
    PubMed     Abstract available


  137. LI X, Marmar T, Xu Q, Tu J, et al
    Predictive indicators of severe COVID-19 independent of comorbidities and advanced age: a nested case-control study.
    Epidemiol Infect. 2020;148:e255.
    PubMed     Abstract available


  138. BRANDL M, Selb R, Seidl-Pillmeier S, Marosevic D, et al
    Mass gathering events and undetected transmission of SARS-CoV-2 in vulnerable populations leading to an outbreak with high case fatality ratio in the district of Tirschenreuth, Germany.
    Epidemiol Infect. 2020;148:e252.
    PubMed     Abstract available


  139. TEIXEIRA R, Doetsch J
    The multifaceted role of mobile technologies as a strategy to combat COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e244.
    PubMed     Abstract available


  140. TAKAYA S, Tsuzuki S, Hayakawa K, Kawashima A, et al
    Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.
    Epidemiol Infect. 2020;148:e250.
    PubMed     Abstract available


  141. GOODALL JW, Reed TAN, Ardissino M, Bassett P, et al
    Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e251.
    PubMed     Abstract available


  142. KHAN ZS, Van Bussel F, Hussain F
    A predictive model for Covid-19 spread - with application to eight US states and how to end the pandemic.
    Epidemiol Infect. 2020;148:e249.
    PubMed     Abstract available


  143. SIFF EJ, Aghagoli G, Gallo Marin B, Tobin-Tyler E, et al
    SARS-CoV-2 transmission: a sociological review.
    Epidemiol Infect. 2020;148:e242.
    PubMed     Abstract available


  144. WANG Y, Xu C, Yao S, Zhao Y, et al
    Forecasting the epidemiological trends of COVID-19 prevalence and mortality using the advanced alpha-Sutte Indicator.
    Epidemiol Infect. 2020;148:e236.
    PubMed     Abstract available


  145. GUO J, Zhou B, Zhu M, Yuan Y, et al
    CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e241.
    PubMed     Abstract available


    September 2020
  146. SHI P, Ren G, Yang J, Li Z, et al
    Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: a multicentre retrospective study.
    Epidemiol Infect. 2020;148:e238.
    PubMed     Abstract available


  147. SINGH D, Joshi K, Samuel A, Patra J, et al
    Alcohol-based hand sanitisers as first line of defence against SARS-CoV-2: a review of biology, chemistry and formulations.
    Epidemiol Infect. 2020;148:e229.
    PubMed     Abstract available


  148. LOPEZ-ABENTE J, Valor-Suarez C, Lopez-Abente G
    Massive application of the SARS-CoV-2 diagnostic test: simulation of its effect on the evolution of the epidemic in Spain.
    Epidemiol Infect. 2020;148:e233.
    PubMed     Abstract available


  149. FERNANDES DE, Ferreira PRA, Mastroianni Kirsztajn G
    Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms?
    Epidemiol Infect. 2020;148:e231.
    PubMed     Abstract available


  150. GUBENSEK J, Vajdic Trampuz B, Persic V, Gregorcic S, et al
    The possibility of SARS-CoV-2 transmission in a haemodialysis unit - report from a large in-hospital centre.
    Epidemiol Infect. 2020;148:e226.
    PubMed     Abstract available


  151. SARASWATHI S, Mukhopadhyay A, Shah H, Ranganath TS, et al
    Social network analysis of COVID-19 transmission in Karnataka, India.
    Epidemiol Infect. 2020;148:e230.
    PubMed     Abstract available


  152. ZONGO P, Zorom M, Mophou G, Dorville R, et al
    A model of COVID-19 transmission to understand the effectiveness of the containment measures: application to data from France.
    Epidemiol Infect. 2020;148:e221.
    PubMed     Abstract available


  153. CHEEMA S, Ameduri M, Abraham A, Doraiswamy S, et al
    The COVID-19 pandemic: the public health reality.
    Epidemiol Infect. 2020;148:e223.
    PubMed     Abstract available


  154. CHEN M, Wei X, Wang Z
    Protecting healthcare workers from SARS-CoV-2 and other infections.
    Epidemiol Infect. 2020;148:e217.
    PubMed     Abstract available


  155. AHMAD I, Muhammad Asad S
    Predictions of coronavirus COVID-19 distinct cases in Pakistan through an artificial neural network.
    Epidemiol Infect. 2020;148:e222.
    PubMed     Abstract available


  156. CHEN LZ, Lin ZH, Chen J, Liu SS, et al
    Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19?
    Epidemiol Infect. 2020;148:e218.
    PubMed     Abstract available


  157. SONG W, Sawafta FJ, Ebrahem BM, Jebril MA, et al
    Public attitude towards quarantine during the COVID-19 outbreak.
    Epidemiol Infect. 2020;148:e220.
    PubMed     Abstract available


  158. DUAN P, Deng ZQ, Pan ZY, Wang YP, et al
    Safety considerations during return to work in the context of stable COVID-19 epidemic control: an analysis of health screening results of all returned staff from a hospital.
    Epidemiol Infect. 2020;148:e214.
    PubMed     Abstract available


  159. HAW NJL, Uy J, Sy KTL, Abrigo MRM, et al
    Epidemiological profile and transmission dynamics of COVID-19 in the Philippines.
    Epidemiol Infect. 2020;148:e204.
    PubMed     Abstract available


  160. TINTO B, Salinas S, Dicko A, Kagone TS, et al
    Spreading of SARS-CoV-2 in West Africa and assessment of risk factors.
    Epidemiol Infect. 2020;148:e213.
    PubMed     Abstract available


  161. PETTI S, Cowling BJ
    Ecologic association between influenza and COVID-19 mortality rates in European countries.
    Epidemiol Infect. 2020 Sep 11:1-21. doi: 10.1017/S0950268820002125.
    PubMed    


  162. ELIMIAN KO, Ochu CL, Ilori E, Oladejo J, et al
    Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February-6 June 2020.
    Epidemiol Infect. 2020;148:e208.
    PubMed     Abstract available


  163. BISWAS RK, Afiaz A, Huq S
    Underreporting COVID-19: the curious case of the Indian subcontinent.
    Epidemiol Infect. 2020;148:e207.
    PubMed     Abstract available


  164. WANG X, Li X, Shang Y, Wang J, et al
    Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
    Epidemiol Infect. 2020;148:e211.
    PubMed     Abstract available


  165. SANTOS MM, Lucena EES, Lima KC, Brito AAC, et al
    Survival and predictors of deaths of patients hospitalised due to COVID-19 from a retrospective and multicentre cohort study in Brazil.
    Epidemiol Infect. 2020;148:e198.
    PubMed     Abstract available


  166. SIMADIBRATA DM, Lubis AM
    D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis.
    Epidemiol Infect. 2020;148:e202.
    PubMed     Abstract available


  167. HAIDER N, Yavlinsky A, Chang YM, Hasan MN, et al
    The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome.
    Epidemiol Infect. 2020;148:e210.
    PubMed     Abstract available


  168. ZHANG L, Huang B, Xia H, Fan H, et al
    Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases.
    Epidemiol Infect. 2020;148:e199.
    PubMed     Abstract available


  169. ZHAO W, Xie X, Liu J
    The importance of distinguishing COVID-19 from more common respiratory illnesses.
    Epidemiol Infect. 2020;148:e195.
    PubMed     Abstract available


  170. CHEN X, Gao H, Zou Y, Lin F, et al
    Changes in psychological wellbeing, attitude and information-seeking behaviour among people at the epicentre of the COVID-19 pandemic: a panel survey of residents in Hubei province, China.
    Epidemiol Infect. 2020;148:e201.
    PubMed     Abstract available


  171. TAN WYT, Wong LY, Leo YS, Toh MPHS, et al
    Does incubation period of COVID-19 vary with age? A study of epidemiologically linked cases in Singapore.
    Epidemiol Infect. 2020;148:e197.
    PubMed     Abstract available


  172. GAYAWAN E, Awe OO, Oseni BM, Uzochukwu IC, et al
    The spatio-temporal epidemic dynamics of COVID-19 outbreak in Africa.
    Epidemiol Infect. 2020;148:e212.
    PubMed     Abstract available


    August 2020
  173. MAMISHI S, Movahedi Z, Mohammadi M, Ziaee V, et al
    Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran.
    Epidemiol Infect. 2020;148:e196.
    PubMed     Abstract available


  174. TEMSAH MH, Alhuzaimi AN, Alamro N, Alrabiaah A, et al
    Knowledge, attitudes and practices of healthcare workers during the early COVID-19 pandemic in a main, academic tertiary care centre in Saudi Arabia.
    Epidemiol Infect. 2020;148:e203.
    PubMed     Abstract available


  175. CHANU AL, Singh RKB
    Stochastic approach to study control strategies of Covid-19 pandemic in India.
    Epidemiol Infect. 2020;148:e200.
    PubMed     Abstract available


  176. HOLDEN B, Quinney A, Padfield S, Morton W, et al
    COVID-19: public health management of the first two confirmed cases identified in the UK.
    Epidemiol Infect. 2020;148:e194.
    PubMed     Abstract available


  177. MIRO O, Llorens P, Jimenez S, Pinera P, et al
    Frequency of five unusual presentations in patients with COVID-19: results of the UMC-19-S1.
    Epidemiol Infect. 2020;148:e189.
    PubMed     Abstract available


  178. KHRAIBANI Z, Khraibani J, Kobeissi M, Atoui A, et al
    Application of records theory on the COVID-19 pandemic in Lebanon: prediction and prevention.
    Epidemiol Infect. 2020;148:e192.
    PubMed     Abstract available


  179. LAI R, Chen E, Gao W, Cheng C, et al
    Sentinel surveillance strategies for early detection of coronavirus disease in fever clinics: experience from China.
    Epidemiol Infect. 2020;148:e205.
    PubMed     Abstract available


  180. DARCIS G, Vaira D, Moutschen M
    Impact of coronavirus pandemic and containment measures on HIV diagnosis.
    Epidemiol Infect. 2020;148:e185.
    PubMed     Abstract available


  181. GOMES DS, Andrade LA, Ribeiro CJN, Peixoto MVS, et al
    Risk clusters of COVID-19 transmission in northeastern Brazil: prospective space-time modelling.
    Epidemiol Infect. 2020;148:e188.
    PubMed     Abstract available


  182. ROUEN A, Adda J, Roy O, Rogers E, et al
    COVID-19: relationship between atmospheric temperature and daily new cases growth rate.
    Epidemiol Infect. 2020;148:e184.
    PubMed     Abstract available


  183. GROTTO RMT, Santos Lima R, de Almeida GB, Ferreira CP, et al
    Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil.
    Epidemiol Infect. 2020;148:e178.
    PubMed     Abstract available


  184. LANARI M, Anderson EJ, Sheridan-Pereira M, Carbonell-Estrany X, et al
    Burden of respiratory syncytial virus hospitalisation among infants born at 32-35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies.
    Epidemiol Infect. 2020;148:e170.
    PubMed     Abstract available


  185. OU M, Zhu J, Ji P, Li H, et al
    Risk factors of severe cases with COVID-19: a meta-analysis.
    Epidemiol Infect. 2020;148:e175.
    PubMed     Abstract available


  186. CHANDA A
    COVID-19 in India: transmission dynamics, epidemiological characteristics, testing, recovery and effect of weather.
    Epidemiol Infect. 2020;148:e182.
    PubMed     Abstract available


  187. JIANG H, Liu JW, Ren N, He R, et al
    Emergency management in fever clinic during the outbreak of COVID-19: an experience from Zhuhai.
    Epidemiol Infect. 2020;148:e174.
    PubMed     Abstract available


  188. LING C, Wen X
    Community grid management is an important measure to contain the spread of novel coronavirus pneumonia (COVID-19).
    Epidemiol Infect. 2020;148:e167.
    PubMed     Abstract available


  189. PIKOVSKI A, Bentele K
    Pooling of coronavirus tests under unknown prevalence.
    Epidemiol Infect. 2020;148:e183.
    PubMed     Abstract available


  190. ADEKUNLE AI, Adegboye OA, Gayawan E, McBryde ES, et al
    Is Nigeria really on top of COVID-19? Message from effective reproduction number.
    Epidemiol Infect. 2020;148:e166.
    PubMed     Abstract available


  191. MA X, Ng M, Xu S, Xu Z, et al
    Development and validation of prognosis model of mortality risk in patients with COVID-19.
    Epidemiol Infect. 2020;148:e168.
    PubMed     Abstract available


  192. YANG H, Chen D, Jiang Q, Yuan Z, et al
    High intensities of population movement were associated with high incidence of COVID-19 during the pandemic.
    Epidemiol Infect. 2020;148:e177.
    PubMed     Abstract available


    July 2020
  193. MAZUMDER A, Arora M, Sra MS, Gupta A, et al
    Geographical variation in case fatality rate and doubling time during the COVID-19 pandemic.
    Epidemiol Infect. 2020;148:e163.
    PubMed     Abstract available


  194. LI L, Chen C
    Contribution of acute-phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19).
    Epidemiol Infect. 2020;148:e164.
    PubMed     Abstract available


  195. ZHANG X, Wang Y
    Prevention and control mechanism for coronavirus disease 2019 epidemic at the primary level: perspective from China.
    Epidemiol Infect. 2020;148:e161.
    PubMed     Abstract available


  196. YANG HM, Lombardi Junior LP, Castro FFM, Yang AC, et al
    Mathematical model describing CoViD-19 in Sao Paulo, Brazil - evaluating isolation as control mechanism and forecasting epidemiological scenarios of release.
    Epidemiol Infect. 2020;148:e155.
    PubMed     Abstract available


  197. LI YH, Fan YZ, Jiang L, Wang HB, et al
    Aerosol and environmental surface monitoring for SARS-CoV-2 RNA in a designated hospital for severe COVID-19 patients.
    Epidemiol Infect. 2020;148:e154.
    PubMed     Abstract available


  198. WENG CH, Saal A, Butt WW, Bica N, et al
    Bacillus Calmette-Guerin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study.
    Epidemiol Infect. 2020;148:e140.
    PubMed     Abstract available


  199. KONG M, Zhang H, Cao X, Mao X, et al
    Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19.
    Epidemiol Infect. 2020;148:e139.
    PubMed     Abstract available


  200. SUN Y, Tian L, Du X, Wang H, et al
    Epidemiological and clinical characteristics of a familial cluster of COVID-19.
    Epidemiol Infect. 2020;148:e145.
    PubMed     Abstract available


  201. XU K, Zhou M, Yang D, Ling Y, et al
    Application of ordinal logistic regression analysis to identify the determinants of illness severity of COVID-19 in China.
    Epidemiol Infect. 2020;148:e146.
    PubMed     Abstract available


  202. QI C, Zhu YC, Li CY, Hu YC, et al
    Epidemiological characteristics and spatial-temporal analysis of COVID-19 in Shandong Province, China.
    Epidemiol Infect. 2020;148:e141.
    PubMed     Abstract available


  203. LI J, Ding J, Chen L, Hong L, et al
    Epidemiological and clinical characteristics of three family clusters of COVID-19 transmitted by latent patients in China.
    Epidemiol Infect. 2020;148:e137.
    PubMed     Abstract available


  204. FENG X, Ding X, Zhang F
    Dynamic evolution of lung abnormalities evaluated by quantitative CT techniques in patients with COVID-19 infection.
    Epidemiol Infect. 2020;148:e136.
    PubMed     Abstract available


  205. QIN W, Sun J, Xu P, Gong T, et al
    The descriptive epidemiology of coronavirus disease 2019 during the epidemic period in Lu'an, China: achieving limited community transmission using proactive response strategies.
    Epidemiol Infect. 2020;148:e132.
    PubMed     Abstract available


    June 2020
  206. LIU Q, Song NC, Zheng ZK, Li JS, et al
    Laboratory findings and a combined multifactorial approach to predict death in critically ill patients with COVID-19: a retrospective study.
    Epidemiol Infect. 2020;148:e129.
    PubMed     Abstract available


  207. LU B, Wang YC, Zhu ZS, Zhang Z, et al
    Epidemiological and genetic characteristics of influenza virus and the effects of air pollution on laboratory-confirmed influenza cases in Hulunbuir, China, from 2010 to 2019.
    Epidemiol Infect. 2020 Jun 29:1-32. doi: 10.1017/S0950268820001387.
    PubMed    


  208. KHALILI M, Karamouzian M, Nasiri N, Javadi S, et al
    Epidemiological characteristics of COVID-19: a systematic review and meta-analysis.
    Epidemiol Infect. 2020;148:e130.
    PubMed     Abstract available


  209. SOUSA GJB, Garces TS, Cestari VRF, Florencio RS, et al
    Mortality and survival of COVID-19.
    Epidemiol Infect. 2020;148:e123.
    PubMed     Abstract available


  210. HAN J, Shi LX, Xie Y, Zhang YJ, et al
    Analysis of factors affecting the prognosis of COVID-19 patients and viral shedding duration.
    Epidemiol Infect. 2020;148:e125.
    PubMed     Abstract available


  211. ENZMANN MO, Erickson MP, Grindeland CJ, Lopez SMC, et al
    Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas.
    Epidemiol Infect. 2020;148:e124.
    PubMed     Abstract available


  212. BRLEK A, Vidovic S, Vuzem S, Turk K, et al
    Possible indirect transmission of COVID-19 at a squash court, Slovenia, March 2020: case report.
    Epidemiol Infect. 2020;148:e120.
    PubMed     Abstract available


  213. YANG L, Dai J, Zhao J, Wang Y, et al
    Estimation of incubation period and serial interval of COVID-19: analysis of 178 cases and 131 transmission chains in Hubei province, China.
    Epidemiol Infect. 2020;148:e117.
    PubMed     Abstract available


  214. FORTALEZA CMCB, Guimaraes RB, de Almeida GB, Pronunciate M, et al
    Taking the inner route: spatial and demographic factors affecting vulnerability to COVID-19 among 604 cities from inner Sao Paulo State, Brazil.
    Epidemiol Infect. 2020;148:e118.
    PubMed     Abstract available


  215. ELLIOT AJ, Harcourt SE, Hughes HE, Loveridge P, et al
    The COVID-19 pandemic: a new challenge for syndromic surveillance.
    Epidemiol Infect. 2020;148:e122.
    PubMed     Abstract available


  216. ZHAO H, Lu X, Deng Y, Tang Y, et al
    COVID-19: asymptomatic carrier transmission is an underestimated problem.
    Epidemiol Infect. 2020;148:e116.
    PubMed     Abstract available


  217. THAI PQ, Toan DTT, Son DT, Van HTH, et al
    Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis.
    Epidemiol Infect. 2020;148:e114.
    PubMed     Abstract available


  218. HAIDER N, Yavlinsky A, Kock R
    Response to 'Evaluation of modelling study shows limits of COVID-19 importing risk simulations in sub-Saharan Africa' (Epidemiology and Infection - HYG-LE-10513-May-20).
    Epidemiol Infect. 2020;148:e112.
    PubMed    


  219. KHOSRAVI A, Chaman R, Rohani-Rasaf M, Zare F, et al
    The basic reproduction number and prediction of the epidemic size of the novel coronavirus (COVID-19) in Shahroud, Iran.
    Epidemiol Infect. 2020;148:e115.
    PubMed     Abstract available


  220. MIYACHI T, Tanimoto T, Kami M
    Evaluation of modelling study shows limits of COVID-19 importing risk simulations in sub-Saharan Africa.
    Epidemiol Infect. 2020;148:e113.
    PubMed     Abstract available


  221. MASSAD E, Amaku M, Wilder-Smith A, Costa Dos Santos PC, et al
    Two complementary model-based methods for calculating the risk of international spreading of a novel virus from the outbreak epicentre. The case of COVID-19.
    Epidemiol Infect. 2020;148:e109.
    PubMed     Abstract available


  222. WALKER MD, Sulyok M
    Online behavioural patterns for Coronavirus disease 2019 (COVID-19) in the United Kingdom.
    Epidemiol Infect. 2020;148:e110.
    PubMed     Abstract available


  223. LIU BM, Yang QQ, Zhao LY, Xie W, et al
    Epidemiological characteristics of COVID-19 patients in convalescence period.
    Epidemiol Infect. 2020;148:e108.
    PubMed     Abstract available


    May 2020
  224. ZHANG J, Wu J, Sun X, Xue H, et al
    Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis.
    Epidemiol Infect. 2020;148:e106.
    PubMed     Abstract available


  225. LIU CY, Yang YZ, Zhang XM, Xu X, et al
    The prevalence and influencing factors in anxiety in medical workers fighting COVID-19 in China: a cross-sectional survey.
    Epidemiol Infect. 2020;148:e98.
    PubMed     Abstract available


  226. SUN D, Yang D, Li Y, Zhou J, et al
    Psychological impact of 2019 novel coronavirus (2019-nCoV) outbreak in health workers in China.
    Epidemiol Infect. 2020;148:e96.
    PubMed     Abstract available


  227. ZHOU ZM, Zhou HZ, Lin XD, Su ZC, et al
    Outbreak of COVID-19 in a family, Wenzhou, China.
    Epidemiol Infect. 2020;148:e103.
    PubMed     Abstract available


  228. CHEN H, Chen Y, Lian Z, Wen L, et al
    Correlation between the migration scale index and the number of new confirmed coronavirus disease 2019 cases in China.
    Epidemiol Infect. 2020;148:e99.
    PubMed     Abstract available


  229. MARSCHNER IC
    Back-projection of COVID-19 diagnosis counts to assess infection incidence and control measures: analysis of Australian data.
    Epidemiol Infect. 2020;148:e97.
    PubMed     Abstract available


  230. MANGIAROTTI S, Peyre M, Zhang Y, Huc M, et al
    Chaos theory applied to the outbreak of COVID-19: an ancillary approach to decision making in pandemic context.
    Epidemiol Infect. 2020;148:e95.
    PubMed     Abstract available


  231. JI M, Yuan L, Shen W, Lv J, et al
    Characteristics of disease progress in patients with coronavirus disease 2019 in Wuhan, China.
    Epidemiol Infect. 2020;148:e94.
    PubMed     Abstract available


    April 2020
  232. MAJOWICZ SE
    What might the future bring? COVID-19 planning considerations for faculty and universities.
    Epidemiol Infect. 2020;148:e92.
    PubMed     Abstract available


  233. YU HP, Ma LL, Hung YY, Wang XB, et al
    Application of 'mobile hospital' against 2019-nCoV in China.
    Epidemiol Infect. 2020;148:e111.
    PubMed    


  234. MORADZADEH R
    The challenges and considerations of community-based preparedness at the onset of COVID-19 outbreak in Iran, 2020.
    Epidemiol Infect. 2020;148:e82.
    PubMed     Abstract available


    March 2020
  235. CRAIG AT, Heywood AE, Hall J
    Risk of COVID-19 importation to the Pacific islands through global air travel.
    Epidemiol Infect. 2020;148:e71.
    PubMed     Abstract available


  236. ER JC, Lium B, Framstad T
    Antibodies of Influenza A(H1N1)pdm09 virus in pigs' sera cross-react with other influenza A virus subtypes. A retrospective epidemiological interpretation of Norway's serosurveillance data from 2009-2017.
    Epidemiol Infect. 2020 Mar 13:1-30. doi: 10.1017/S0950268820000643.
    PubMed    


    February 2020
  237. HAIDER N, Yavlinsky A, Simons D, Osman AY, et al
    Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America.
    Epidemiol Infect. 2020;148:e41.
    PubMed     Abstract available


  238. TASIAME W, Johnson S, Burimuah V, Akyereko E, et al
    Outbreak of Highly Pathogenic Avian Influenza in Ghana, 2015: degree of losses and outcomes of time-course outbreak management.
    Epidemiol Infect. 2020 Feb 17:1-19. doi: 10.1017/S095026882000045.
    PubMed    


  239. MAO H, Sun Y, Chen Y, Lou X, et al
    Co-circulation of influenza A(H1N1), A(H3N2), B(Yamagata) and B(Victoria) during the 2017-2018 influenza season in Zhejiang Province, China.
    Epidemiol Infect. 2020 Feb 14:1-13. doi: 10.1017/S0950268820000412.
    PubMed    


  240. CHEN Y, Leng K, Lu Y, Wen L, et al
    Epidemiological features and time-series analysis of influenza incidence in urban and rural areas of Shenyang, China, 2010-2018.
    Epidemiol Infect. 2020;148:e29.
    PubMed     Abstract available


  241. TIN TIN HTAR M, Yerramalla MS, Moisi JC, Swerdlow DL, et al
    The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis.
    Epidemiol Infect. 2020;148:e48.
    PubMed     Abstract available


  242. MCCLOSKEY B, Heymann DL
    SARS to novel coronavirus - old lessons and new lessons.
    Epidemiol Infect. 2020;148:e22.
    PubMed     Abstract available


    December 2019
  243. LIU W, Dai Q, Bao J, Shen W, et al
    Influenza activity prediction using meteorological factors in a warm temperate to subtropical transitional zone, Eastern China.
    Epidemiol Infect. 2019;147:e325.
    PubMed     Abstract available


  244. MARTIN LJ, Dong H, Liu Q, Talbot J, et al
    Predicting influenza-like illness-related emergency department visits by modelling spatio-temporal syndromic surveillance data.
    Epidemiol Infect. 2019;147:e312.
    PubMed     Abstract available


    November 2019
  245. MINNEY-SMITH CA, Selvey LA, Levy A, Smith DW, et al
    Post-pandemic influenza A/H1N1pdm09 is associated with more severe outcomes than A/H3N2 and other respiratory viruses in adult hospitalisations.
    Epidemiol Infect. 2019;147:e310.
    PubMed     Abstract available


  246. LIPSITCH M, Goldstein E, Ray GT, Fireman B, et al
    Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results.
    Epidemiol Infect. 2019;147:e306.
    PubMed     Abstract available


  247. YANG J, Li H, Jia L, Lan X, et al
    High expression levels of influenza virus receptors in airway of the HBV-transgenic mice.
    Epidemiol Infect. 2019;147:e297.
    PubMed     Abstract available


    October 2019
  248. SCOTT EM, Magaret A, Kuypers J, Tielsch JM, et al
    Risk factors and patterns of household clusters of respiratory viruses in rural Nepal.
    Epidemiol Infect. 2019;147:e288.
    PubMed     Abstract available


    September 2019
  249. CHEN LL, Wu WL, Chan WM, Fong CHY, et al
    Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains.
    Epidemiol Infect. 2019;147:e279.
    PubMed     Abstract available


  250. KALISH T, Miron D, Azrad M, Rechnitzer H, et al
    Characteristics of hospitalised patients with influenza in 2015-2016 in northern Israel: three circulating strains and continued fear of 2009 A/H1N1.
    Epidemiol Infect. 2019;147:e278.
    PubMed     Abstract available


  251. SUN X, Douiri A, Gulliford M
    Pneumonia incidence trends in UK primary care from 2002 to 2017: population-based cohort study.
    Epidemiol Infect. 2019;147:e263.
    PubMed     Abstract available


    January 2019
  252. PRASAD N, Newbern EC, Trenholme AA, Wood T, et al
    Respiratory syncytial virus hospitalisations among young children: a data linkage study.
    Epidemiol Infect. 2019;147:e246.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: